← Association for Accessible Medicines
FDANonrulemakingFDA-2017-N-6644

Generic Drug User Fee Amendments Reauthorization of 2017; Regulatory Science Initiatives; Public Workshop

RIN
—
Last modified
May 31, 2022
Comment window
closed 1509d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Jun 26, 2018 and Jun 26, 2018. 0 other organizations filed here. The comment window closed 1509d ago.

What Association for Accessible Medicines filed (1)

Jun 26, 2018· Comment from Association for Accessible Medicines· FDA-2017-N-6644-0006

The Association for Accessible Medicines (AAM) acknowledges the efforts of the FDA on Docket Number FDA-2017-N-6644 concerning comments following the May 24th GDUFA Regulatory Science Public Workshop. We would also like to thank you for the opportunity to share our thoughts on this important public health issue.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (0)

See everyone who commented →